Tower Research Capital LLC (Trc) Avalo Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.0 - $10.45 $43,647 - $152,037	-14,549 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$7.57 - $21.72 $53,754 - $154,233	7,101 Added 95.34%	14,549 $11,000
Q4 2021 Feb 14, 2022	SELL	$19.68 - $28.68 $16,531 - $24,091	-840 Reduced 10.14%	7,448 $13,000
Q3 2021 Nov 15, 2021	BUY	$26.16 - $40.68 $216,814 - $337,155	8,288 New	8,288 $18,000

34.6K

Ticker AVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,414,100
Market Cap $84.9M
Description
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.